Use and approval of antihypertensive agents and surrogate endpoints for the approval of drugs affecting antiarrhythmic heart failure and hypolipidemia.

Use and approval of antihypertensive agents and surrogate endpoints for the approval of drugs affecting antiarrhythmic heart failure and hypolipidemia. Proceedings of the 10th annual symposium on new drugs & devices, October 31 -November 1, 1989. Onder redactie van J. Morganroth en E.N. Moore. (Developments in cardiovascular medicine.) 230 bl…